Research Site
Fresh Meadows, New York 11366
1 studies enrolling now · 15 studies all time
What they study most
Anxiety, Anxiety Disorders, Anxiety Neuroses, Anxiety States, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small Cell Lung, Chronic Kidney Disease, Colorectal Cancer, Depression, Depressive Disorder, Depressive Disorder, Major
Studies at this site
- A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer — Recruiting now
- Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE) — Running, not enrolling
- A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer. — Running, not enrolling
- A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease — Stopped early
- A Study to Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients. — Completed
- Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis — Completed
- First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX — Completed
- JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab — Completed
- AZD9291 US Expanded Access Program — NO_LONGER_AVAILABLE
- Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial) — Completed
- A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder — Completed
- Iressa Expanded Access Program (EAP) — Completed
- AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD) — Completed
- Generalized Anxiety Disorder Adjunct Study — Completed
- The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer — Stopped early